Calcium Antagonists in Heart Failure

[1]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study , 1987 .

[2]  N. Taira,et al.  Differences in cardiovascular profile among calcium antagonists. , 1987, The American journal of cardiology.

[3]  P. Vanhoutte The expert committee of the World Health Organization on classification of calcium antagonists: the viewpoint of the raporteur. , 1987, The American journal of cardiology.

[4]  R. Cody,et al.  Effect of nicardipine on rest and exercise hemodynamics in chronic congestive heart failure. , 1986, The American journal of cardiology.

[5]  G. Tamborini,et al.  Nitrendipine vs. Long-Acting Nifedipine in Mild, Moderate and Severe Hypertension , 1986, Angiology.

[6]  F. Tristani,et al.  Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure , 1986 .

[7]  R. Cody,et al.  Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. , 1985, American heart journal.

[8]  C. McKay,et al.  Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. , 1985, The American journal of cardiology.

[9]  J. Hill,et al.  Coronary and systemic hemodynamic effects of nicardipine. , 1985, The American journal of cardiology.

[10]  B. Lorell,et al.  Inotropic, vascular and neuroendocrine effects of nifedipine in heart failure: comparison with nitroprusside. , 1985, Journal of the American College of Cardiology.

[11]  D. McGill,et al.  The acute haemodynamic effects of oral nicardipine. , 1985, British journal of clinical pharmacology.

[12]  A. Stella,et al.  Adrenergic Sodium Handling and the Natriuretic Action of Calcium Antagonists , 1985, Journal of cardiovascular pharmacology.

[13]  M. Vincent,et al.  Effects of nicardipine and nisoldipine on myocardial metabolism, coronary blood flow and oxygen supply in angina pectoris. , 1984, The American journal of cardiology.

[14]  E. Raftery,et al.  Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina. , 1984, Journal of the American College of Cardiology.

[15]  V. Legrand,et al.  Hemodynamic effects of intravenous diltiazem with impaired left ventricular function. , 1984, The American journal of cardiology.

[16]  C. McKay,et al.  Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct-acting agonism with hydralazine in chronic refractory congestive heart failure. , 1984, The American journal of cardiology.

[17]  C. Cipolla,et al.  Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle. , 1984, American heart journal.

[18]  C. McKay,et al.  Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure. , 1984, The American journal of cardiology.

[19]  P. Ludbrook,et al.  The dependence of the cardiac effects of nifedipine on the responses of the peripheral vascular system. , 1984, Circulation.

[20]  C. Porter,et al.  Beneficial hemodynamic effects of intravenous and oral diltiazem in severe congestive heart failure. , 1984, Journal of the American College of Cardiology.

[21]  M. Rousseau,et al.  Calcium Antagonism Free of Negative Inotropic Effects - a Comparison of Intracoronary Nifedipine and Nicardipine , 1984 .

[22]  T. Levine,et al.  Acute Hemodynamic Effects of Nitrendipine in Chronic Congestive Heart Failure , 1984, Journal of cardiovascular pharmacology.

[23]  J. Laragh,et al.  Evaluation of calcium-mediated vasoconstriction in chronic congestive heart failure. , 1983, The American journal of medicine.

[24]  J. Cohn,et al.  Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure. , 1983, Journal of the American College of Cardiology.

[25]  R. Cody,et al.  Circulatory autoregulation in chronic congestive heart failure: responses to head-up tilt in 41 patients. , 1983, The American journal of cardiology.

[26]  L. Hansson,et al.  Pharmacokinetic and pharmacodynamic parameters in patients treated with nitrendipine. , 1983, Hypertension.

[27]  R. Hornung,et al.  The Effect of a New Calcium Channel Blocker Nicardipine on 24‐hour Ambulatory Blood Pressure and the Pressor Response to Isometric and Dynamic Exercise , 1983, Journal of hypertension.

[28]  R. Hof Calcium antagonist and the peripheral circulation: differences and similarities between PY 108–068, nicardipine, verapamil and diltiazem , 1983, British journal of pharmacology.

[29]  P. Turner,et al.  Acute haemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine. , 1983, British journal of clinical pharmacology.

[30]  G. Ansalone,et al.  Oral Nifedipine in the Long‐Term Management of Severe Chronic Heart Failure , 1982, Journal of cardiovascular pharmacology.

[31]  S. Oparil,et al.  The role of calcium in the control of renin release. , 1982, Hypertension.

[32]  J. Laragh,et al.  Mechanisms Governing the Postural Response and Baroreceptor Abnormalities in Chronic Congestive Heart Failure: Effects of Acute and Long‐term Converting‐enzyme Inhibition , 1982, Circulation.

[33]  H. Hecht,et al.  Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease. , 1981, The American journal of cardiology.

[34]  E. Antman,et al.  Calcium channel blocking agents in the treatment of cardiovascular disorders. Part II: Hemodynamic effects and clinical applications. , 1980, Annals of internal medicine.

[35]  P. D. Henry Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. , 1980, The American journal of cardiology.

[36]  R. Balcon,et al.  Unpredictable response to nifedipine in severe cardiac failure. , 1980, British medical journal.

[37]  K. Catt,et al.  Dependence of aldosterone stimulation in adrenal glomerulosa cells on calcium uptake: effects of lanthanum nd verapamil. , 1980, Endocrinology.

[38]  R. Gagnon,et al.  Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure. , 1980, Chest.

[39]  D. Gillmer,et al.  Pulmonary oedema precipitated by nifedipine. , 1980, British medical journal.

[40]  F. Camerini,et al.  Haemodynamic effects of nifedipine in heart failure. , 1980, British heart journal.

[41]  M. Olivari,et al.  Clinical use of a calcium antagonistic agent (nifedipine) in acute pulmonary edema. , 1979, The American journal of medicine.

[42]  M. Olivari,et al.  Treatment of Hypertension with Nifedipine, A Calcium Antagonistic Agent , 1979, Circulation.

[43]  Bramahn . Singh,et al.  Effects of intravenous verapamil on hemodynamics in patients with heart disease. , 1977, American heart journal.

[44]  J. Cohn,et al.  Vasodilator Therapy of Cardiac Failure , 1977 .